US Research reveals the role of Heparan Sulfate in Obesity

AMSBIO reports how researchers at the Washington University School of Medicine (St. Louis, USA) have used their 10E4 Heparan Sulfate (HS) antibody in pioneering obesity research to quantify the role of HS in the...

What happens in our brain when we die

Neuroscientists have recorded the activity of a dying human brain and discovered rhythmic brain wave patterns similar to those during dreaming, memory recall, and meditation. A new study suggests an explanation for vivid life...

Lab-grown ‘mini-stomachs’ could shed light on children’s COVID symptoms

A ‘lab-grown model’ of the human stomach, that can be used to study how infections affect the gastrointestinal system, has been developed for the first time. A UCL-led team of international scientists have built on...

Ancient genes help dolphins live on

Ancient genes that predate the last Ice Age may be the key to survival … at least if you are a dolphin! Genes up to 2.3 million years old helped the bottlenose dolphin adapt to...

Sizzling breakthrough for 3D meat

A 4oz steak has been ‘lab-grown’ using a digital design file. Israeli firm MeaTech 3D Ltd. cultivated the bio-printed steak using real fat and muscle cells. The cells were produced using an advanced process that...

USA Based Angstrom Technology Acquire UK Market-Leader Connect 2 Cleanrooms

ASGARD Partners & Co., LLC ("ASGARD"), a New York-based private equity firm, today announced that its portfolio company, Angstrom Technology ("Angstrom" or the "Company"), an industry leader in modular cleanroom design and production, has signed...

Pioneering breakthrough in treatment of ‘devastating’ neurological disorder

IntraBio Inc has announced positive data from its multinational clinical trial of IB1001 for the treatment of GM2 Gangliosidosis (Tay-Sachs and Sandhoff disease). IB1001 demonstrated a statistically significant and clinically meaningful improvement in symptoms, functioning,...

AI could improve diagnosis for over 100,000 prostate patients in UK

The use of AI to identify prostate cancer is currently being validated in the first retrospective study of its kind in the UK. Real-world data from hospitals and scanner types is being scrutinised, to show...

Advances in longitudinal RWD and genomics access for drug development in Africa

A new partnership aims to build the largest integrated clinical and genomics data biobank in Africa, representing a major boost for RWD research across the continent. The collaboration is between BC Platforms (BCP), a global...

Novel mechanism links IBD genetic defect to gut leakiness

A study into ‘leaky gut’ is the first to show how a disease mutation increases the risk of developing Inflammatory Bowel Disease (IBD). Researchers led by a biomedical scientist at the University of California, Riverside,...

Antimicrobial resistance ‘arms race’ heats up

An advanced interventional microbiomics company, which is developing non-antibiotic methods for the control of multiple-drug resistant superbugs and other infectious disease, is stepping up development of a cure for antibiotic resistant bacteria. BioPlx has set...

Nemera’s preservative-free multi-dose eyedropper approved in Brazil for Aché’s NSAID’s and Dry Eye formulations

Nemera is excited to announce that its multidose eye dropper Novelia® has been approved by ANVISA for the preservative-free formulations CLILON (Ketorolac 0,4% and 0,5%), a nonsteroidal anti-inflammatory drug (NSAID) that is used...

Legal Cannabis Market in Europe Set to be Worth €3.2 billion by 2025

The European cannabis market is forecast to grow with a compound annual growth rate (CAGR) of 67.4% to reach €3.2 billion by 2025, a new report has found. The European Cannabis Report: 6th Edition, released...

Zotefoams hosts virtual opening of new £23million plant in Poland

Over 140 customers from 21 countries today attended the virtual opening of Zotefoams’ new state-of-the-art plant located in Brzeg in south-west Poland. In a key strategic move to increase global capacity and optimise service...

Nemera to acquire Copernicus to boost parenteral product portfolio and small series capabilities

This acquisition strengthens Nemera’s proprietary product offering and establishes operations footprint in Eastern Europe. Nemera today announced that they have entered into an agreement to acquire Copernicus. Copernicus, based in Szczecin Poland, specializes in the...

Safe’n’Spray: Winner at CPhI Festival of Pharma

Nemera’s  concept device Safe'n'SprayTM was rewarded under the category 'Excellence in Pharma - Drug Delivery Devices'. This recognition was announced during the awards ceremony on 13 October 2020 on the digital platform of CPhI Festival of Pharma. Safe’n’Spray is...